Exhibit 99.A4
LICENSE AGREEMENT
THIS LICENSE AGREEMENT (this "AGREEMENT") is made and entered into
as of the 8th day of November, 2002 (the "COMMENCEMENT DATE") by and between The
Bank of New York, having an office at Xxx Xxxx Xxxxxx, Xxx Xxxx, XX 00000
("LICENSOR"), and Nasdaq Financial Products Services, Inc. ("Licensee"), having
an office at 0000 Xxx Xxxx Xxx., Xxxxxxxxx, XX 00000.
RECITALS
WHEREAS, Licensor asserts that it compiles, calculates and maintains
the indexes specified on Schedule I hereto, and owns certain rights in and to
such indexes and the proprietary data contained therein, and Licensor asserts
that it owns or has the rights to license the marks listed in Schedule I hereto
(such marks being hereinafter collectively referred to as the "LICENSOR MARKS",
and such rights, including, without limitation, copyright, trademark, service
xxxx or proprietary rights and trade secrets, being hereinafter collectively
referred to as the "INTELLECTUAL PROPERTY"); and
WHEREAS, Licensee wishes to use certain of such indexes and the
related Licensor Marks, pursuant to the terms and conditions hereinafter set
forth, in connection with (i) the issuance, marketing and promotion of the
Products (as defined in Section 1(c)) and (ii) making disclosure about such
Products under applicable laws, rules and regulations in order to indicate that
Licensor is the source of such indexes.
NOW, THEREFORE, in consideration of the mutual undertakings
contained herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto agree as
follows:
1. Grant of License.
(a) In consideration of the payment of royalties and license and
administrative fees pursuant to Section 3, and subject to the terms and
conditions of this Agreement, Licensor hereby grants to Licensee a
non-transferable (except to subsidiaries pursuant to Section 12(a)),
non-exclusive license (i) to use the Indexes (as defined in subsection (b)
below) solely in connection with the issuance or trading, as the case may be, of
the Products to be issued or traded, as the case may be, by Licensee, in the
territories listed in Schedule II hereto (the "TERRITORIES") and (ii) to use and
refer to the Licensor Marks in connection with the marketing and promotion of
the Products in order to indicate that the Products are based on the Indexes and
that Licensor is the source of the Indexes (but not the Products), and as may
otherwise be required by applicable laws, rules or regulations or under this
Agreement.
(b) As used in this Agreement, "INDEXES" means the indexes listed on
Schedule III hereto (and the indexes to be added thereto in accordance with the
provisions set forth therein).
(c) As used in this Agreement, "PRODUCTS" means the products
designated on Schedule IV hereto that are issued by Licensee and based upon one
or more of the Indexes (but, except as otherwise specified in Schedule II
hereto, not any part or subset of the components of any Index) and correlated to
the underlying securities comprising such Indexes. The terms of the Products,
and any material changes therein, shall be subject to Licensor's prior written
consent.
(d) Nothing contained in this Agreement shall restrict Licensor from
licensing any one or more indexes (including the Indexes) or any of the Licensor
Marks to any other Person at any time.
(e) Nothing contained in this Agreement constitutes a license to
Licensee to use any one or more of the Indexes other than in connection with the
issuance, marketing and promotion of the Products within the Territories.
(f) Licensee acknowledges that the Indexes and the Licensor Marks
are the property of Licensor. Except as otherwise specifically provided in this
Agreement, Licensor reserves all rights to the Indexes and the Licensor Marks,
and this Agreement shall not be construed to transfer to Licensee any ownership
right to, or equity interest in, any of the Indexes or the Licensor Marks, or in
any Intellectual Property or other proprietary rights pertaining thereto.
(g) Licensee acknowledges that the Indexes, their compilation and
composition, and any changes therein, are and will remain in the complete
control and sole discretion of Licensor. Without limiting the foregoing,
Licensor shall have the exclusive right, in its sole discretion and at any time,
to modify the methodology for determining the composition of, or calculating,
any of the Indexes or any other features or characteristics thereof.
(h) Licensor or its Affiliates shall not independently enter into
transactions with respect to, or issue, sponsor, distribute, advise or provide
other services with respect to, exchange-traded funds which are based upon the
Indexes and which may be similar to, or competitive with, the Products. This
paragraph is not intended to restrict the Licensor from licensing the Indexes
in conjunction with trading of the Products on an unlisted trading privileges
basis.
2. Term.
(a) Subject to subsection (b) below, the term of this Agreement
shall commence on the Commencement Date and shall continue until the third
anniversary of the Commencement Date, unless this Agreement is terminated
earlier as provided in Section 4 (such term, the "INITIAL TERM").
(b) This Agreement shall be extended beyond the Initial Term if (i)
at least ninety (90) days prior to expiration of the Initial Term (other than by
reason of termination of this Agreement as provided in Section 4), Licensee
shall deliver to Licensor a notice in writing of its desire to extend the
Initial Term and (ii) the parties hereto shall agree on the terms and license
fees to be applicable during such extension (the term of any such extension, the
"EXTENDED TERM", and the Initial Term and any Extended Term together, the
"TERM").
3. License Fees.
(a) In consideration for the license granted in this Agreement,
Licensee shall pay to Licensor royalties and license and administrative fees
(collectively, "LICENSE FEES") as set forth in Schedule V hereto. Except as
otherwise provided in such Schedule IV, Licensee shall pay all License Fees to
Licensor within thirty (30) days after the end of each calendar quarter. (b)
Licensor shall have the right at any time, upon written request and upon
reasonable notice, to audit on a confidential basis and during normal business
hours, the relevant books and records of Licensee to confirm the accuracy of any
one or more calculations of License Fees. Such audit shall be conducted by
auditors selected by Licensor in its reasonable judgment. If an audit conducted
pursuant to this subsection (b) discloses any overpayment or underpayment of
License Fees by Licensee, Licensor or Licensee, as the case may be, shall
promptly make the requisite adjustments for such repayment or underpayment.
Licensor shall bear its own costs of any such audit unless it is determined that
Licensor has been underpaid by 5% or more with respect to the payments being
audited, in which case Licensor's costs of such audit shall be paid by Licensee.
4. Termination.
(a) If there is a material breach of this Agreement by any party
(such party, the "BREACHING PARTY" and, the other party, the "NON-BREACHING
PARTY"), or if any party (such party, the "HARMED PARTY") believes in good faith
that material damage or harm is occurring to its reputation or goodwill by
reason of its continued performance under this Agreement (other than pursuant to
Section 4(d)), then the Non-breaching Party or the Harmed Party, as the case may
be, may terminate this Agreement, effective thirty (30) days after written
notice thereof is given to the other party (with reasonable specificity as to
the nature of the breach or the condition causing such damage or harm, as the
case may be, and including a statement as to such party's intent to terminate),
unless the Breaching Party shall correct such breach or the condition causing
such damage or harm, as the case may be, to the reasonable satisfaction of the
Non-breaching Party within such 30-day period.
(b) Licensee may terminate this Agreement upon ninety (90) days'
prior written notice to Licensor (or such lesser period of time as may be
necessary pursuant to law, rule, regulation or court order) if: (i) any
legislation or regulation is finally adopted,
or any government interpretation is issued, that prevents Licensee from issuing,
marketing or promoting the Products; (ii) any material litigation or regulatory
proceeding regarding the Products is commenced if such litigation or proceeding
prevents Licensee from issuing, promoting or marketing the Products or
materially increases the costs or reduces the economic benefits of doing so or
otherwise materially prejudices Licensee; (iii) Licensee elects to terminate the
offering or other distribution of the Products; or (iv) any of the events set
forth in Section 4(c)(i), (ii) or (iii) occurs.
(c) Licensor may terminate this Agreement upon ninety (90) days'
prior written notice to Licensee if: (i) any legislation or regulation is
finally adopted or any government interpretation is finally issued that
generally prevents third-party licensees from issuing, marketing or promoting
the Products; (ii) any material litigation or regulatory proceeding regarding
the Products is commenced; (iii) any legislation or regulation is finally
adopted or any government interpretation is finally issued that materially
impairs Licensor's ability to license the Licensor Marks or the Indexes; (iv)
any of the terms or conditions of this Agreement, or the performance thereof, in
the reasonable judgment of Licensor after consultation with counsel or by
determination or written directive of any governmental or self-regulatory
authority or agency with jurisdiction over it, (A) would be reasonably likely to
exceed the operating powers of Licensor or any of its Affiliates, (B) would
violate any law, regulation, order or judgment applicable to Licensor or any of
its Affiliates, (C) would be reasonably likely to subject Licensor or any of its
Affiliates to regulatory action or (D) would render it inadvisable for Licensor,
in view of concerns by applicable regulatory authorities expressed in writing or
directed specifically to Licensor or any of its Affiliates, to continue this
Agreement; or (v) any of the events set forth in Section 4(b)(i) through (iii)
occurs.
(d) Notwithstanding anything in this Agreement to the contrary,
Licensor shall have the right to cease compiling, calculating and publishing
values of any Indexes at any time in its sole discretion and thereupon to
terminate this Agreement with respect to such Indexes upon written notice to
Licensee; provided that Licensor shall use commercially reasonable efforts to
provide Licensee with as much prior notice as is reasonably practicable under
the circumstances.
(e) Notwithstanding anything in this Agreement to the contrary, if
any exchange: (i) ceases to provide data necessary for providing the Indexes to
all data vendors, providers and publishers; (ii) terminates all such data
vendors', providers' and publishers' rights to receive data in the form of a
"feed" from such exchange; (iii) materially restricts all such data vendors',
providers' and publishers' rights to redistribute data received from such
exchange; or (iv) institutes charges of a type or to an extent applicable to all
such data vendors, providers and publishers (and not to others generally) for
the provision of data to such data vendors, providers and publishers or the
redistribution of data by them in amounts materially greater than those in
effect as of the date of this Agreement, Licensor may terminate this Agreement
with regard to any one or more Indexes upon as much prior written notice to
Licensee as is reasonably practicable under the circumstances.
5. Licensor's Obligations.
(a) Licensor is not, and shall not be, obligated to, but may, engage
in any way or to any extent in (i) any marketing or promotional activities
relating to the Products or (ii) making any representation or statement to
investors or prospective investors in connection with the marketing or promotion
of the Products by Licensee.
(b) Licensor agrees to provide reasonable support for Licensee's
development and educational efforts with respect to the Products as follows:
(i) Licensor shall respond in a timely fashion to any
reasonable requests from Licensee for information regarding the Indexes;
(ii) Licensor or its agent shall, or shall arrange for a third
party vendor to, calculate and disseminate the value of the Indexes in
accordance with Licensor's current procedures, which procedures may be
modified by Licensor in its sole discretion at any time; and
(iii) Licensor shall promptly correct, or instruct its agent
to correct, any material mathematical errors made in Licensor's
computations of the Indexes which are brought to Licensor's attention by
Licensee; provided that nothing in this Section 5 shall give Licensee the
right to exercise any judgment or require any changes with respect to
Licensor's method of composing, calculating or determining the Indexes;
provided, further, that nothing in this Section 5 shall be deemed to
modify the provisions of Section 9.
6. Trademark Filings; Recognition of Intellectual Property Rights;
Protection of Intellectual Property; Quality Control.
(a) Licensor shall apply for such trademark and trade name
registrations for the Licensor Marks only in such jurisdictions, if any, where
Licensor, in its sole discretion, considers such filings appropriate. Licensee
shall, at Licensor's expense, reasonably cooperate with Licensor in the
maintenance of such rights and registrations, and shall perform such acts and
execute such instruments as may be reasonably requested in writing by Licensor
for such purpose. Licensee shall use the following statement (or such similar
language as may be approved in advance in writing by Licensor) when referring to
any of the Indexes or any of the Licensor Marks in any informational materials
to be used in connection with the Products (including all prospectuses,
registration statements, trade confirmations and agreements, advertisements,
brochures and promotional and any other similar informational materials,
including documents required to be filed with governmental or regulatory
agencies) that in any way use or refer to Licensor, any of its subsidiaries or
Affiliates, any of the Indexes or any of the Licensor Marks (collectively, the
"INFORMATIONAL MATERIALS"):
"BNY", "The Bank of New York Asia 50 ADR Index", "The Bank of New
York Developed Markets 100 ADR Index",
"The Bank of New York Emerging Markets 50 ADR Index", "The Bank of
New York Europe 100 ADR Index" and The BNY Asia 50 ADR Index", "The
BNY Developed Markets 100 ADR Index", "The BNY Emerging Markets 50
ADR Index", "The BNY Europe 100 ADR Index"" are service marks of The
Bank of New York and have been licensed for use for certain purposes
by Nasdaq Financial Products Services, Inc. ("NFPS"). NFPS's "BLDRS
ASIA 50 ADR INDEX FUND", "BLDRS DEVELOPED MARKETS 100 ADR INDEX
FUND", "BLDRS EMERGING MARKETS 50 ADR INDEX FUND" AND "BLDRS EUROPE
100 ADR INDEX FUND" based on the] "The Bank of New York Asia 50 ADR
Index", "The Bank of New York Developed Markets 100 ADR Index", "The
Bank of New York Emerging Markets 50 ADR Index", "The Bank of New
York Europe 100 ADR Index" are not sponsored, endorsed, sold,
recommended or promoted by The Bank of New York or any of its
subsidiaries or affiliates, and none of The Bank of New York or any
of its subsidiaries or affiliates makes any representation or
warranty, express or implied, to the purchasers or owners of the
"BLDRS ASIA 50 ADR INDEX FUND", "BLDRS DEVELOPED MARKETS 100 ADR
INDEX FUND", "BLDRS EMERGING MARKETS 50 ADR INDEX FUND" AND "BLDRS
EUROPE 100 ADR INDEX FUND" or any member of the public regarding the
advisability of investing in financial products generally or in the
"BLDRS ASIA 50 ADR INDEX FUND", "BLDRS DEVELOPED MARKETS 100 ADR
INDEX FUND", "BLDRS EMERGING MARKETS 50 ADR INDEX FUND" AND "BLDRS
EUROPE 100 ADR INDEX FUND" particularly, the ability of the "The
Bank of New York Asia 50 ADR Index", "The Bank of New York Developed
Markets 100 ADR Index", "The Bank of New York Emerging Markets 50
ADR Index", "The Bank of New York Europe 100 ADR Index" to track
market performance or the suitability or appropriateness of the
"BLDRS ASIA 50 ADR INDEX FUND", "BLDRS DEVELOPED MARKETS 100 ADR
INDEX FUND", "BLDRS EMERGING MARKETS 50 ADR INDEX FUND" AND "BLDRS
EUROPE 100 ADR INDEX FUND" for such purchasers, owners or such
member of the public. The relationship between The Bank of New York,
as Licensor, on one hand, and NFPS on the other, is limited to the
licensing of certain trademarks and trade names of The Bank of New
York and of the "The Bank of New York Asia 50 ADR Index", "The Bank
of New York Developed Markets 100 ADR Index", "The Bank of New York
Emerging Markets 50 ADR Index", "The Bank of New York Europe 100 ADR
Index", which index is determined, composed and calculated by The
Bank of New York without regard to NFPS or the "BLDRS ASIA 50 ADR
INDEX FUND", "BLDRS DEVELOPED MARKETS 100 ADR INDEX FUND", "BLDRS
EMERGING MARKETS 50 ADR INDEX FUND" AND "BLDRS EUROPE 100 ADR INDEX
FUND" . Neither The Bank of New York nor any of its subsidiaries
or affiliates has any obligation to take the needs of NFPS or the
purchasers or owners of the "BLDRS ASIA 50 ADR INDEX FUND", "BLDRS
DEVELOPED MARKETS 100 ADR INDEX FUND", "BLDRS EMERGING MARKETS 50
ADR INDEX FUND" AND "BLDRS EUROPE 100 ADR INDEX FUND" into
consideration in determining, composing or calculating the "The Bank
of New York Asia 50 ADR Index", "The Bank of New York Developed
Markets 100 ADR Index", "The Bank of New York Emerging Markets 50
ADR Index", "The Bank of New York Europe 100 ADR Index" . Neither
The Bank of New York nor any of its subsidiaries or affiliates is
responsible for, or has participated in, the determination of the
timing of, prices at, or quantities of the "BLDRS ASIA 50 ADR INDEX
FUND", "BLDRS DEVELOPED MARKETS 100 ADR INDEX FUND", "BLDRS EMERGING
MARKETS 50 ADR INDEX FUND" AND "BLDRS EUROPE 100 ADR INDEX FUND" ]
to be issued or in the determination or calculation of the equation
by which the "BLDRS ASIA 50 ADR INDEX FUND", "BLDRS DEVELOPED
MARKETS 100 ADR INDEX FUND", "BLDRS EMERGING MARKETS 50 ADR INDEX
FUND" AND "BLDRS EUROPE 100 ADR INDEX FUND" is to be converted into
cash. NEITHER THE BANK OF NEW YORK NOR ANY OF ITS SUBSIDIARIES OR
AFFILIATES GUARANTEES THE ACCURACY OR COMPLETENESS OF "THE BANK OF
NEW YORK ASIA 50 ADR INDEX", "THE BANK OF NEW YORK DEVELOPED MARKETS
100 ADR INDEX", "THE BANK OF NEW YORK EMERGING MARKETS 50 ADR
INDEX", "THE BANK OF NEW YORK EUROPE 100 ADR INDEX" OR ANY DATA
INCLUDED THEREIN, AND NEITHER THE BANK OF NEW YORK NOR ANY OF ITS
SUBSIDIARIES OR AFFILIATES SHALL HAVE ANY LIABILITY FOR ANY ERRORS,
OMISSIONS OR INTERRUPTIONS THEREIN. NEITHER THE BANK OF NEW YORK NOR
ANY OF ITS SUBSIDIARIES OR AFFILIATES MAKES ANY WARRANTY, EXPRESS OR
IMPLIED, AS TO RESULTS TO BE OBTAINED BY NFPS, PURCHASERS OR OWNERS
OF THE "BLDRS ASIA 50 ADR INDEX FUND", "BLDRS DEVELOPED MARKETS 100
ADR INDEX FUND", "BLDRS EMERGING MARKETS 50 ADR INDEX FUND" AND
"BLDRS EUROPE 100 ADR INDEX FUND" OR ANY OTHER PERSON OR ENTITY FROM
THE USE OF THE "THE BANK OF NEW YORK ASIA 50 ADR INDEX", "THE BANK
OF NEW YORK DEVELOPED MARKETS 100 ADR INDEX", "THE BANK OF NEW YORK
EMERGING MARKETS 50 ADR INDEX", "THE BANK OF NEW YORK EUROPE 100 ADR
INDEX" OR ANY DATA INCLUDED THEREIN. NEITHER THE BANK OF NEW YORK
NOR ANY OF ITS SUBSIDIARIES OR AFFILIATES MAKES ANY EXPRESS OR
IMPLIED WARRANTIES, AND EXPRESSLY DISCLAIMS ALL WARRANTIES OF
MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE WITH
RESPECT TO THE "THE BANK OF NEW YORK ASIA 50 ADR INDEX", "THE BANK
OF NEW YORK DEVELOPED MARKETS 100 ADR INDEX", "THE BANK OF NEW YORK
EMERGING MARKETS 50 ADR INDEX", "THE BANK OF NEW YORK EUROPE 100 ADR
INDEX" OR ANY DATA INCLUDED THEREIN. WITHOUT LIMITING ANY OF THE
FOREGOING, IN NO EVENT SHALL THE BANK OF NEW YORK OR ANY OF ITS
SUBSIDIARIES OR AFFILIATES HAVE ANY LIABILITY FOR ANY SPECIAL,
PUNITIVE, INDIRECT OR CONSEQUENTIAL DAMAGES (INCLUDING, WITHOUT
LIMITATION, LOST PROFITS), EVEN IF NOTIFIED OF THE POSSIBILITY OF
SUCH DAMAGES.
(b) Licensee agrees that the Licensor Marks and all Intellectual
Property and other rights, registrations and entitlement thereto, together with
all applications, registrations and filings with respect to any of the Licensor
Marks and any renewals and extensions of any such applications, registrations
and filings, are and shall remain the sole and exclusive property of Licensor or
its subsidiaries and Affiliates. Licensee acknowledges that each of the Licensor
Marks is part of the business and good will of Licensor or its subsidiaries and
Affiliates, and agrees that it shall not contest the fact that Licensee's rights
in the Licensor Marks under this Agreement (i) are limited solely to the use of
the Licensor Marks in connection with the issuance, marketing or promotion of
the Products and disclosure about the Products under applicable law as provided
in Section 1(a), and (ii) shall cease upon the termination or expiration of this
Agreement, except as otherwise expressly provided herein. Upon termination of
this Agreement, Licensee shall have no further rights to use any Licensor Xxxx
in any form whatsoever. Licensee recognizes the value of the reputation and good
will associated with the Licensor Marks and acknowledges that any such good will
belongs to Licensor or its subsidiaries and Affiliates, and that Licensor or its
subsidiaries and Affiliates, are the owners of all right, title and interest in
and to the Licensor Marks, including, without limitation, their use in
connection with the Products. Licensee further acknowledges that all rights in
any translations, derivations or modifications of the Licensor Marks which may
be created by or for Licensee shall be and remain the exclusive property of
Licensor or its subsidiaries and Affiliates, and such property shall be and
remain a part of the Intellectual Property subject to the provisions and
conditions of this Agreement. Licensee shall not, either directly or indirectly,
contest the ownership of any of the Intellectual Property. Licensee shall not,
except with Licensor's prior written consent, use any Licensor Xxxx, or the
designations "The Bank of New York", "BNY" or any other Licensor Xxxx, in
conjunction with Licensee's own trademark(s) or service xxxx(s). Licensee agrees
to cooperate with Licensor in the maintenance of such rights and registrations,
and shall perform such acts, and execute such instruments, as may be reasonably
requested in writing by Licensor for such purpose.
(c) In the event Licensor terminates this Agreement pursuant to
Section 4(a), or Licensee terminates this Agreement pursuant to Section 4(a) or
4(b)(i), (ii) or (iii), or the Term expires pursuant to Section 2, Licensor
shall, at the time the notice of
such termination is furnished, or upon expiration of the Term, as the case may
be, continue to provide to Licensee a non-exclusive license to continue to use
the Indexes exclusively with respect to Products previously issued by Licensee
that are and remain outstanding and trading as of the effective date of such
termination or expiration (the "ISSUED PRODUCTS"), and Licensee shall continue
to be bound by all of the obligations of Licensee, and Licensor shall continue
to be entitled to all of the rights of Licensor set forth in this Agreement with
respect to the Issued Products, notwithstanding such termination or expiration
of this Agreement. Such license shall be effective as of the effective date of
termination or expiration of this Agreement, and remain effective until the last
of the Issued Products matures, expires or terminates in accordance with its
terms (without extension thereof by amendment or otherwise). Under no
circumstances shall such license apply to the issuance of any Product by
Licensee on or after the effective date of termination or expiration of this
Agreement. Notwithstanding the foregoing, if Licensor terminates this Agreement
pursuant to Section 4(a), Licensor's obligation to continue to provide a license
shall be subject to Licensee's curing, within thirty (30) days after the
effective date of termination, the breach or harm giving rise to Licensor's
termination right under Section 4(a). Licensee shall not, as of the effective
date of termination or expiration of this Agreement, make reference to, or use
in any manner or for any purpose, the Licensor Marks, except as set forth in
this Section 6(c) or as required by applicable law, rule, regulation or court
order. In no event shall Licensee issue, trade, market or promote any Product
based on one or more of the Indexes on or after the effective date of
termination or expiration of this Agreement, as the case may be, except as
provided in this Section 6(c).
(d) Notwithstanding anything in this Agreement to the contrary,
Licensee may use the Licensor Marks after the effective date of termination for
the purpose of providing any notification of such termination as it relates to
the Products; provided that the form and substance of any such notification
shall be subject to the prior written approval of Licensor.
(e) In the event that Licensee learns of any infringement or
imitation of any of the Indexes or the Intellectual Property, or of any use by
any Person of a xxxx similar to any of the Licensor Marks, it shall promptly
notify Licensor thereof. Licensor may take such action, if any, as it deems
advisable for the protection of rights in and to the Indexes and the Licensor
Marks and, if requested to do so by Licensor, Licensee shall cooperate with
Licensor in all reasonable respects, at Licensor's expense. Moreover, Licensee
shall not initiate any action asserting rights with respect to any of Licensor's
Intellectual Property without the express written consent of Licensor. Any duty
of cooperation in litigation by Licensee shall not be deemed to be a waiver of
Nasdaq's attorney-client, attorney work product, or other legal privileges.
(f) Licensee shall use its commercially reasonable efforts to
protect the good will and reputation of Licensor and its subsidiaries and
Affiliates, the Indexes and the Intellectual Property in connection with its use
of the Indexes and any Licensor Marks under this Agreement, including, but not
limited to, maintaining high standards of accuracy in advertisements, brochures
and promotional and informational materials using
such Indexes and Licensor Marks. Licensee shall submit to Licensor, for
Licensor's review and approval, and Licensee shall not use until receiving
Licensor's approval thereof in writing, all Informational Materials that in any
way use or refer to Licensor, any of its subsidiaries or Affiliates, any of the
Indexes or any of the Licensor Marks. Licensor's approval shall be required with
respect to the use and description of Licensor, any of its subsidiaries or
Affiliates, any of the Indexes or any of the Licensor Marks. Licensor shall
notify Licensee of its approval or disapproval of any Informational Materials
within 72 hours (excluding any day which is a Saturday or Sunday or a day on
which The Nasdaq Stock Market is closed for business) following receipt thereof
from Licensee. Notwithstanding the foregoing, Licensor shall have the right at
any time to modify the use or description of Licensor, any of its subsidiaries
or Affiliates, such Indexes or such Licensor Marks, as the case may be, in the
Informational Materials so approved, upon as much prior written notice to
Licensee as is reasonably practicable under the circumstances.
(g) (i) Licensee shall not use, nor permit the use of, any of the
Licensor Marks in any Informational Material as part of a composite xxxx with
any of its own marks, the marks of any of its Affiliates or the marks of any
third party (collectively, the "NON-LICENSOR MARKS"), and (ii) the Licensor
Marks and the Non-Licensor Marks, to the extent they appear in any Informational
Material, shall appear separately and shall be clearly identified with regard to
ownership. Whenever the Licensor Marks are used in any Informational Material in
connection with any of the Products, the name of Licensee shall appear in close
proximity to the Licensor Marks so that the identity of Licensee, and its status
as an authorized licensee of such Licensor Marks, is clear and obvious.
(h) Licensee agrees that any change proposed by Licensee with
respect to (i) the terms and conditions of the Products or (ii) the use of the
Licensor Marks shall be submitted to Licensor for, and shall be subject to,
Licensor's prior written consent.
(i) If at any time Licensor is of the good faith opinion that
Licensee is not properly using the Intellectual Property in connection with the
Products or Informational Materials, or that the standard of quality of any of
the Products or Informational Materials does not conform to appropriate
commercial standards, Licensor shall give notice to Licensee to that effect.
Upon receipt of such notice, Licensee shall forthwith correct the defects
therein, or shall forthwith cease the issuance, marketing, promotion and sale or
use of the non-conforming Products or Informational Materials.
7. Proprietary Rights.
(a) Licensee acknowledges that Licensor asserts that the Indexes are
selected, compiled, coordinated, arranged and prepared by Licensor through the
application of methods and standards of judgment used and developed through the
expenditure of considerable work, time and money. Licensee also acknowledges
that Licensor asserts that the Indexes and the Intellectual Property are
valuable assets of Licensor, and agrees that it will take reasonable measures to
prevent any unauthorized
use of the information provided to it concerning the selection, compilation,
coordination, arrangement and preparation of the Indexes.
(b) Each party shall treat as confidential and proprietary, and
shall not disclose or transmit to any third party, (i) any documentation or
other materials that are marked as "confidential" by the providing party, (ii)
any and all data and historical data regarding the Indexes and their constituent
securities, (iii) any information relating to the calculation methodology for
any of the Indexes or (iv) any of the terms of this Agreement (collectively,
"CONFIDENTIAL INFORMATION"); provided that Confidential Information shall not
include (A) any information that is available to the public or to the receiving
party from sources other than the providing party (provided that such source, to
the best of such receiving party's knowledge, is not subject to any
confidentiality obligations with regard to such information) or (B) any
information that is independently developed by the receiving party without use
of or reference to information from the providing party.
(c) Notwithstanding anything in subsection (b) above to the
contrary, any party may reveal Confidential Information to any regulatory agency
or court of competent jurisdiction if such information to be disclosed is (i)
approved in writing by the providing party for disclosure or (ii) required by
applicable law, regulatory agency or court order to be disclosed by the
receiving party; provided that, if permitted by law, prior written notice of
such required disclosure shall be given to the providing party; provided,
further, that the receiving party shall cooperate with the providing party to
limit the extent of such disclosure.
(d) The provisions of subsections (b) and (c) above shall survive
the termination or expiration of this Agreement for a period of five (5) years
from disclosure by either party to the other of the last item of such
Confidential Information.
8. Warranties; Disclaimers.
(a) Each party represents and warrants that it has the authority to
enter into this Agreement according to its terms, and that the execution and
delivery by it of this Agreement and the performance by it of its obligations
hereunder will not violate any other agreement applicable to it or any
applicable law or regulation. Licensee represents and warrants to Licensor that
the issuance, marketing, promotion, sale and resale of the Products by it will
not violate any agreement applicable to it or any applicable laws, rules or
regulations, including, without limitation, securities, commodities and banking
laws.
(b) Licensee covenants and agrees with Licensor that the Products
shall at all times comply with the descriptions thereof set forth on Schedule
III.
(c) Licensee expressly agrees to be bound by the terms of the
statement set forth in Section 6(a), which terms are expressly incorporated
herein by reference and made a part hereof.
(d) Notwithstanding any other provision of this Agreement to the
contrary, and without limiting the disclaimers set forth in this Agreement
(including, without limitation, in the statement set forth in Section 6(a), in
no event: (i) shall the cumulative liability of Licensor to Licensee and its
Affiliates under or relating to this Agreement at any time exceed the aggregate
amount of License Fees received by Licensor pursuant to this Agreement prior to
such time; (ii) shall Licensor be liable for any special, consequential or
punitive damages for any act or omission in connection with this Agreement or
the performance hereof; or (iii) shall Licensor have any liability for any Loss
(as defined in Section 9(a)) incurred by Licensee in connection with Licensee's
use of any of the Licensor Marks or the Indexes or the exercise of its rights
under this Agreement, except to the extent that such Loss was directly and
proximately caused by the gross negligence or willful misconduct of either of
the Licensor or by a material breach of Licensor's representations and
warranties under this Agreement.
9. Indemnification.
(a) Licensee shall indemnify and hold harmless Licensor and its
Affiliates, officers, directors, members, employees and agents against any and
all judgments, damages, liabilities, costs and losses of any kind (including,
without limitation, reasonable attorneys' and experts' fees and expenses)
(collectively, "LOSSES") as a result of any claim, action or proceeding that
arises out of or relates to this Agreement, the Products or Licensee's use of
the Indexes or the Licensor Marks; provided, however, that Licensor shall
promptly notify Licensee in writing of any such claim, action or proceeding (but
the failure to do so shall not relieve Licensee of any liability under this
Agreement except to the extent Licensee has been materially prejudiced thereby).
Licensee may elect, by written notice to Licensor within ten (10) days after
receiving notice of such claim, action or proceeding from Licensor, to assume
the defense thereof with counsel reasonably acceptable to Licensor. If Licensee
does not so elect to assume such defense, or disputes its indemnity obligation
with respect to such claim, action or proceeding, or if Licensor reasonably
believes that there are conflicts of interest between Licensor and Licensee or
that additional defenses are available to Licensor with respect to such defense,
then Licensor shall retain their own counsel to defend such claim, action or
proceeding, at Licensee's expense; provided that, if, in the reasonable judgment
of Licensor, any such claim, action or proceeding could, or could be expected
to, affect the rights of Licensor in or to any of the Licensor Marks or the
Indexes, Licensor may elect to control the defense of such claim, action or
proceeding; provided, further, that any such election to control shall not
affect any of the obligations of Licensee under this Agreement. Licensee shall
periodically reimburse Licensor for its expenses incurred under this Section
9(a). Licensor shall have the right, at its expense, to participate in the
defense of any claim, action or proceeding against which they are indemnified
under this Agreement and with respect to which Licensee has, subject to the
provisions of this paragraph (a), assumed the defense; provided, however, that
Licensor shall have no right to consent to judgment or agree to settle any such
claim, action or proceeding, without the prior written consent of Licensee,
which consent shall not be unreasonably withheld. Except with the prior written
consent of Licensor, Licensee, in the defense of any such claim, action or
proceeding, shall not consent to entry of any judgment or enter into any
settlement. In no event shall Licensee, without the prior written consent of
Licensor, consent to the entry of any judgment, or enter into any settlement
which (i) does not include, as an unconditional term, the grant by the claimant
to Licensor and all Persons with rights of indemnification under this Agreement
of a release of all liabilities in respect of such claims or (ii) otherwise
adversely affects the rights of Licensor and all Persons with rights of
indemnification under this Agreement.
(b) Licensor shall indemnify and hold harmless Nasdaq and its
Affiliates, officers, directors, members, employees and agents against any and
all Losses as a result of any claim, demand, action, suit or proceeding
(collectively, "DISPUTE") that arises out of or relates to any third party
asserting that the Indexes and/or any Intellectual Property of Licensor licensed
to Licensee hereunder infringes any Intellectual Property right of any third
party; provided, however, that Licensee shall promptly notify Licensor in
writing of any such Dispute (but the failure to do so shall not relieve Licensor
of any liability under this Agreement except to the extent Licensor has been
materially prejudiced thereby). Licensor may elect, by written notice to
Licensee within ten (10) days after receiving notice of such Dispute from
Licensor, to assume the defense thereof with counsel reasonably acceptable to
Licensee. If Licensor does not so elect to assume such defense, or disputes its
indemnity obligation with respect to such Dispute, or if Licensee reasonably
believes that there are conflicts of interest between Licensor and Licensee or
that additional defenses are available to Licensee with respect to such defense,
then Licensee shall retain their own counsel to defend such claim, action or
proceeding, at Licensor's expense; provided that, if, in the reasonable judgment
of Licensee, any such Dispute could, or could be expected to, affect the rights
of Licensee in or to any of the Licensee Products (except Licensee's ability to
use the Licensor Marks or the Indexes), Licensee may elect to control the
defense of such Dispute; provided, further, that any such election to control
shall not affect any of the obligations of Licensor under this Agreement.
Licensor shall periodically reimburse Licensee for its expenses incurred under
this Section 9(b). Licensee shall have the right, at its expense, to participate
in the defense of any Dispute against which they are indemnified under this
Agreement and with respect to which Licensor has, subject to the provisions of
this paragraph (b), assumed the defense; provided, however, that Licensee shall
have no right to consent to judgment or agree to settle any such claim, action
or proceeding, without the prior written consent of Licensor, which consent
shall not be unreasonably withheld. Except with the prior written consent of
Licensee, Licensor, in the defense of any such claim, action or proceeding,
shall not consent to entry of any judgment or enter into any settlement. In no
event shall Licensor, without the prior written consent of Licensee, consent to
the entry of any judgment, or enter into any settlement which (i) does not
include, as an unconditional term, the grant by the claimant to Licensee and all
Persons with rights of indemnification under this Agreement of a release of all
liabilities in respect of such claims or (ii) otherwise adversely affects the
rights of Licensee and all Persons with rights of indemnification under this
Agreement.
(c) The indemnification provisions set forth in this Section 9 are
solely for the benefit of Licensor and other Persons with rights of
indemnification under this
Agreement, and are not intended to, and do not, create any rights or causes of
actions on behalf of any third party.
10. Suspension of Performance.
Notwithstanding anything in this Agreement to the contrary, neither
Licensor nor Licensee shall bear any responsibility or liability for any Losses
arising out of any delay in, or interruptions of, performance of their
respective obligations under this Agreement due to any act of God, act of
governmental authority or act of public enemy, or due to war, the outbreak or
escalation of hostilities, riot, fire, flood, civil commotion, insurrection,
labor difficulty (including, without limitation, any strike, other work
stoppage, or slow-down), severe or adverse weather conditions, power failure,
communications or other technological failure or any other similar cause found
to be beyond the reasonable control of the party so affected; provided, however,
that this Section 10 shall not affect a party's obligations under Section 9 in
respect of any claim, action or proceeding brought by a third party.
11. Injunctive Relief.
In the event of a material breach by one party of any of the
provisions of this Agreement relating to Confidential Information of the other
party, the Breaching Party acknowledges and agrees that damages would be an
inadequate remedy and that the Non-breaching Party shall be entitled, in
addition to any money damages, to preliminary and permanent injunctive relief to
preserve such confidentiality or limit improper disclosure of such Confidential
Information; provided that nothing in this Agreement shall preclude the
Non-breaching Party from pursuing any other action or remedy for any breach or
threatened breach of this Agreement. All remedies under this Section 11 shall be
cumulative.
12. Miscellaneous.
(a) This Agreement is solely and exclusively among the parties
hereto and, except to the extent otherwise expressly provided in this Agreement,
shall not be assigned or transferred, nor shall any duty hereunder be delegated,
by any party, without the prior written consent of the other parties, and any
attempt to so assign or transfer, or delegate any duty under this Agreement
without such written consent, shall be null and void; provided, however, that
any wholly-owned subsidiary of Licensee may use the Indexes and the Licensor
Marks in connection with the issuance, marketing and promotion of the Products;
provided, further, that such subsidiary shall be, and Licensee shall remain,
subject to all of the terms and conditions of this Agreement applicable to
Licensee; provided, further, that notwithstanding anything in the foregoing to
the contrary, Licensor may assign this Agreement, in whole or in part, to any
Affiliate through which Licensor conducts all or a part of its business relating
to the licensing of Licensor Marks or Indexes. This Agreement shall be valid and
binding on the parties hereto and their successors and permitted assigns.
(b) This Agreement, including the Schedules and Exhibits hereto
(which are hereby expressly incorporated into and made a part of this
Agreement), constitutes the entire agreement of the parties hereto with respect
to its subject matter. This Agreement supersedes any and all previous
agreements, written, oral or in electronic form, among the parties with respect
to the subject matter of this Agreement. There are no oral or written collateral
representations, agreements or understandings except as provided in this
Agreement.
(c) No waiver, modification or amendment of any of the terms and
conditions of this Agreement shall be valid or binding unless set forth in a
written instrument signed by duly authorized officers of all parties. The delay
or failure by any party to insist, in any one or more instances, upon strict
performance of any of the terms or conditions of this Agreement, or to exercise
any right or privilege herein conferred, shall not be construed as a waiver of
any such term, condition, right or privilege, but the same shall continue in
full force and effect.
(d) No breach, default or threatened breach of this Agreement by any
party shall relieve any other party of its obligations or liabilities under this
Agreement with respect to the protection of the property or proprietary nature
of any property which is the subject of this Agreement.
(e) All notices and other communications under this Agreement shall
be (i) in writing, (ii) delivered by hand (with written confirmation of
receipt), by registered or certified mail (return receipt requested) or by
facsimile transmission (with confirmation of receipt), to the addresses or
facsimile numbers set forth below or to such other addresses or facsimile
numbers as either party shall specify by written notice to the other parties,
and (iii) deemed given upon receipt.
If to Licensor:
The Bank of New York
000 Xxxxxxx Xxxxxx, 00xx Xxxxx
Xxx Xxxx, XX 00000
Attn.: ADR Division
Fax No.: (000) 000-0000
If to Licensee:
Nasdaq Financial Products Services, Inc.
0000 Xxx Xxxx Xxxxxx
Xxxxxxxxx XX 00000
Attn: Xxxx Xxxxxx
Executive Vice President
Fax No.: (000) 000-0000
(f) This Agreement shall be governed by, and construed in accordance
with, the laws of the State of New York. Each party agrees that any legal
action, proceeding, controversy or claim between the parties arising out of or
relating to this Agreement may be brought only in the United States District
Court for the Southern District of New York or in the Supreme Court of the State
of New York in and for the First Judicial Department, and by execution of this
Agreement each party submits to the exclusive jurisdiction of such court and
waives any objection it might have based upon improper venue or inconvenient
forum. Each party hereto hereby waives any right it may now or in the future
have to a jury trial in connection with any legal action, proceeding,
controversy or claim between any of the parties arising out of or relating to
this Agreement.
(g) This Agreement (and any related arrangements between the
parties) is solely and exclusively for the benefit of the parties, their
respective subsidiaries and Affiliates, and their respective successors and
permitted assigns, and nothing in this Agreement (or any related arrangements
between the parties), express or implied, is intended to or shall confer on any
other Person (including, without limitation, any sublicensee of Licensee under
this Agreement or any purchaser of any Products issued by Licensee), any rights,
benefits or remedies of any nature whatsoever under or by reason of this
Agreement (or any such related arrangements between the parties).
(h) Sections 6(b), (c) and (d), 7(b), (c) and (d) (as provided
therein), 8, 9, 11, 12(f) and (p) and this Section 12(h) shall survive the
expiration or termination of this Agreement.
(i) The parties are independent contractors. Nothing in this
Agreement shall be construed to place the parties in the relationship of
partners or joint venturers, and neither party shall acquire any power, other
than as specifically and expressly provided in this Agreement, to bind the other
in any manner whatsoever with respect to third parties.
(j) All references herein to "commercially reasonable efforts" shall
include taking into account all relevant commercial and regulatory factors. All
references herein to "regulations" or "regulatory proceedings" shall include
regulations or proceedings by self-regulatory organizations such as securities
exchanges.
(k) If any term or provision of this Agreement, or the application
thereof to any Person or circumstance, shall to any extent be held invalid or
unenforceable by a court of competent jurisdiction, such result shall not affect
the other terms and provisions of this Agreement or the application thereof
which can be given effect without the relevant term, provision or application,
and to this end the parties agree that the provisions of this Agreement are and
shall be severable.
(l) All rights, privileges and remedies afforded the parties by this
Agreement shall be deemed cumulative and not exclusive. In the event of a breach
or other failure to perform as required under this Agreement, the non-breaching
or
defaulting entity shall, in addition to all rights and remedies herein provided,
have all rights and remedies available at law or in equity.
(m) This Agreement may be executed in counterparts, each of which
shall be deemed an original, but all of which together shall constitute one
instrument.
(n) For purposes of this Agreement: "PERSON" means any individual,
corporation, partnership, joint venture, association, joint stock company, trust
or unincorporated association; and "AFFILIATE" means, with respect to any party,
any Person directly or indirectly controlling, controlled by, or under common
control with, such party; "control" when used with respect to any Person means
the power to direct the management and policies of such Person, directly or
indirectly, whether through the ownership of voting securities, by contract or
otherwise; and the terms "controlling" and "controlled" have meanings
correlative to the foregoing.
[THIS SPACE INTENTIONALLY LEFT BLANK.]
IN WITNESS WHEREOF, THE PARTIES HAVE CAUSED THIS AGREEMENT TO BE EXECUTED AS OF
THE DATE FIRST SET FORTH ABOVE.
THE BANK OF NEW YORK
By: /s/ Xxxxx Xxxxxx
------------------------------------------
Name: Xxxxx Xxxxxx
------------------------------------------
Title: Vice President
------------------------------------------
Authorized Officer
NASDAQ FINANCIAL PRODUCTS SERVICES, INC.
By: /s/ Xxxx X. Xxxxxx
------------------------------------------
Name: Xxxx X. Xxxxxx
------------------------------------------
Title: Chief Executive Officer
------------------------------------------
Authorized Officer
SCHEDULE I
INDEXES AND LICENSOR MARKS
BNY
The Bank of New York Asia 50 ADR Index
The Bank of New York Developed
Markets 100 ADR Index
The Bank of New York Emerging
Markets 50 ADR Index
The Bank of New York Europe
100 ADR Index
The BNY Asia 50 ADR Index
The BNY Developed Markets 100 ADR Index
The BNY Emerging Markets 50 ADR Index
The BNY Europe 100 ADR Index
I-1
SCHEDULE II
TERRITORIES
Worldwide
II-1
SCHEDULE III
INDEXES BEING LICENSED
BNY Asia 50 ADR Index
BNY Developed Markets 100 ADR Index
BNY Emerging Markets 50 ADR Index
BNY Europe 100 ADR Index
III-1
SCHEDULE IV
PRODUCTS DESCRIPTION
BLDRS Asia 50 ADR Index Fund (ADRA)
BLDRS Developed Markets 100 ADR Index Fund (ADRD)
BLDRS Emerging Markets 50 ADR Index Fund (ADRE)
BLDRS Europe 100 ADR Index Fund (ADRU)
IV-1
SCHEDULE V
ROYALTIES, LICENSE AND ADMINISTRATIVE FEES
License Fees to be paid at a rate of 6/100 of one percent (0.06%) per annum,
times the average daily net asset value of BLDRS Index Funds Trust (the
"Trust"), provided that, to the extent that the ordinary operating expenses of
any series of the Trust (each, a "Fund") exceed an amount which is 30/100 of one
percent (0.30%) per year of the average daily net asset value of such Fund
during any fiscal year, (the "Expense Cap") Licensor shall waive licensing fees
applicable to such Fund.
Licensee shall pay the fees in accordance with the following:
1. Licensee shall pay to The Bank of New York a license fee at the rate of
6/100 of one percent (0.06%) per annum, times the average daily net asset value
of each Fund (the "Annual Fee").
2. The Annual Fee shall be computed and paid as follows:
a. At the end of each quarter during a Contract Year (ending on the three
month anniversary of the Effective Date of the prior quarter), Licensee shall
calculate the average daily net asset value of each Fund during the quarter by
(i) adding together the daily net asset values of such Fund, as determined by
The Bank of New York, in its capacity as trustee of the Trust (the "Trustee") on
each business day during the quarter, and then (ii) dividing such sum by the
number of daily net asset values determined in (i) above. The resulting average
daily net asset value shall then be multiplied by .0006 and divided by four,
resulting in the quarterly License Fee due to Licensor by Licensee.
b. Each quarterly payment shall be subordinated to all other operating
expenses and paid only when funds are available within the Expense Cap. Amounts
due from prior quarters shall continue to be payable in the next quarter until
the end of the fiscal year. Each quarter a statement setting forth the
calculations on license fees and operating expenses shall be provided to
Licensor.
V-1
